banner add

Executives Depart Cassava, Maker of Disputed Alzheimer’s Drug

July 19, 2024 0
The chief executive and a lead scientist stepped down weeks after a federal grand jury filed fraud charges against a research collaborator.

from NYT > Health https://ift.tt/pTq5nkA
via IFTTT
Tags:

No comments

Subscribe to: Post Comments ( Atom )

Brenna Henn Wanted to Improve Genetic Medicine. Then Her N.I.H. Grant Was Cut.

Brenna Henn had a long-term grant to study the genetic diversity of Africans and people of African descent. Then her N.I.H. funding was cut....

Theme images by PLAINVIEW. Powered by Blogger.